Evidence map›Paper›PMID 27767186›Full record

ArticleScientific reports2016

Recombinant Reg3β protein protects against streptozotocin-induced β-cell damage and diabetes.

Chen Luo, Lu-Ting Yu, Meng-Qi Yang, Xiang Li, Zhi-Yuan Zhang, Martin O Alfred, Jun-Li Liu, Min Wang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Development for Probiotics Based Insulin Delivery System.Current issues in molecular biology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Reg3 Proteins as Gut Hormones?Endocrinology · 2019
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Chen LuoSchool of Life Science &Technology, China Pharmaceutical University, Nanjing, China.
Lu-Ting YuSchool of Life Science &Technology, China Pharmaceutical University, Nanjing, China.
Meng-Qi YangSchool of Life Science &Technology, China Pharmaceutical University, Nanjing, China.
Xiang LiSchool of Life Science &Technology, China Pharmaceutical University, Nanjing, China.
Zhi-Yuan ZhangSchool of Life Science &Technology, China Pharmaceutical University, Nanjing, China.
Martin O AlfredSchool of Life Science &Technology, China Pharmaceutical University, Nanjing, China.
Jun-Li LiuFraser Laboratories for Diabetes Research, Department of Medicine, McGill University Health Centre, Montreal, Canada.
Min WangSchool of Life Science &Technology, China Pharmaceutical University, Nanjing, China.
China Pharmaceutical University · CNMcGill University Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regenerating genes (Reg) have been found during the search for factors involved in pancreatic islet regeneration. Our recent study discovered that pancreatic β-cell-specific overexpression of Reg3β protects against streptozotocin (Stz) -induced diabetes in mice. To investigate its potential roles in the treatment of diabetes, we produced a recombinant Reg3β protein and provided evidence that it is active in promoting islet β-cell survival against Stz- triggered cell death. Though ineffective in alleviating preexisting diabetes, pretreatment of recombinant Reg3β was capable of minimizing the Stz-induced hyperglycemia and weight loss, by preserving serum and pancreatic insulin levels, and islet β-cell mass. No obvious changes were observed in the rate of cell proliferation and hypertrophy in α- or acinar-cells after treatment with recombinant Reg3β. The underlying mechanism of Reg3β-mediated protection seems to involve Akt activation which upregulates Bcl-2 and Bcl-xL levels and consequently promotes cell survival.

Indexed as

Acinar CellsAnimalsCell CycleCell LineCell SurvivalDiabetes Mellitus, ExperimentalGlucagon-Secreting CellsInsulinInsulin-Secreting CellsMaleMiceMice, Inbred BALB CPancreas, ExocrinePancreatitis-Associated ProteinsProtective AgentsProto-Oncogene Proteins c-bcl-2InsulinPancreatitis-Associated ProteinsProtective AgentsProto-Oncogene Proteins c-bcl-2Recombinant ProteinsReg3b protein, mouse

Identifiers

PMID27767186
PMCPMC5073304
OpenAlexW2534202907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.